99TH GENERAL ASSEMBLY
State of Illinois
2015 and 2016
HB5949
 
Introduced , by Rep. Michael J. Zalewski
 
SYNOPSIS AS INTRODUCED:
 

 
225 ILCS 85/16c

     Amends the Pharmacy Practice Act. Extends the repeal of the medicine locking closure package pilot program from January 1, 2017 to January 1, 2018. Effective immediately.
  


LRB099 15930 MLM 40247 b

FISCAL NOTE ACT MAY APPLY
 
 
A BILL FOR
 

  
HB5949LRB099 15930 MLM 40247 b


  
1    AN ACT concerning regulation.
  
 
2    Be it enacted by the People of the State of Illinois,
 
3represented in the General Assembly:
  
 
 
4    Section 5. The Pharmacy Practice Act is amended  by changing 
5Section 16c as follows:
 
6    (225 ILCS 85/16c)
7    (Section scheduled to be repealed on January 1, 2017)
8    Sec. 16c. Medicine locking closure package.
9    (a) As used in this Section: 
10    "Medicine locking closure package" means any alphanumeric 
11combination locking closure mechanism that can only be unlocked 
12with a user-generated, resettable alphanumeric code in 
13combination with an amber prescription container that forms a 
14package that allows only the person with a prescription access 
15to the medicine.
16    "Schedule II controlled substance" means a Schedule II 
17controlled substance under the United States Controlled 
18Substances Act and 21 CFR 1308. 
19    (b) Subject to appropriation, effective January 1, 2016, 
20the Department shall by rule implement a pilot project 
21requiring that every new or refilled prescription for a 
22Schedule II controlled substance containing hydrocodone 
23dispensed by a pharmacy that voluntarily decides to participate 
 
 
HB5949- 2 -LRB099 15930 MLM 40247 b

1in the pilot program shall only be dispensed in a non-reusable 
2medicine locking closure package. The Department shall not 
3expend more than $150,000 on this pilot program. The Department 
4may contract with third parties to implement the pilot program 
5in whole or in part.
6    (c) The medicine locking closure package must be dispensed 
7by the pharmacy with instructions for patient use unless the 
8prescriber indicates orally, in writing, or electronically 
9that a medicine locking closure package shall not be used.
10    (d) The manufacturer of the medicine locking closure 
11package must make available assistance online or through a 
12toll-free number for patient use.
13    (e) Prescriptions reimbursed via the Medicare Part D and 
14Medicaid programs, including Medicaid managed care plans, are 
15exempt from the provisions of this Section.
16    (f) Prescriptions for individuals residing in facilities 
17licensed under the Nursing Home Care Act are exempt from the 
18provisions of this Section.
19    (g) This Section is repealed on January 1, 2018 2017. 

20(Source: P.A. 99-473, eff. 8-27-15.)
 
 
21    Section 99. Effective date. This Act takes effect upon 
22becoming law.